Home/Spero Therapeutics/Timothy Keutzer

TK

Timothy Keutzer

Chief Operating Officer

Spero Therapeutics

Therapeutic Areas

Infectious Diseases Rare Diseases

Spero Therapeutics Pipeline

Drug	Indication	Phase
Tebipenem HBr (tebipenem pivoxil hydrobromide)	Complicated Urinary Tract Infection (cUTI), including pyelonephritis	Phase 3
SPR720	Nontuberculous Mycobacterial (NTM) Pulmonary Disease	Phase 2

Leadership Team at Spero Therapeutics

Esther Rajavelu

President and Chief Executive Officer

Senior Vice President of Finance and Business Operations

Senior Vice President Controller

View full Spero Therapeutics profile